Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Phio Pharmaceuticals Corp
PHIO
Healthcare
Biotechnology
Phio Pharmaceuticals Corp. is a clinical-stage biotechnology company. The Company's INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. It is developing therapeutics that are designed to leverage INTASYL to target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or...
drug delivery systems. The Company's pipeline is focused on the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma. Its product pipeline includes PH-762 and PH-894. PH-762 is an INTASYL compound designed to reduce the expression of cell death protein 1 (PD-1). PD-1 is a protein that inhibits T cells’ ability to kill cancer cells and is a clinically validated target in immunotherapy. PH-894 is an INTASYL compound that is designed to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, thereby affecting the immune system as well as the tumor.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:PHIO)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 1:52pm
PHIO.....volume just increased on the 5 min chrt
price also....but has to bust thru the $2.25 area
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 1:46pm
PHIO.... Time is running out for this?
Is this coiling for the Power Hour rip at 12 noon???? Or it this just taking on more prisoners like it usually does?? Time will tell
New PEA Indicates an Ultra Low-Cost Uranium Project with Huge Exploration Upside
posted Apr 26, 2024 9:00am by
Blue Sky Uranium Corp
-
|
This PEA reaffirms that the deposit is a leading low-cost uranium-vanadium project. We believe that this resurgent uranium market has a strong long-term outlook and we are therefore preparing to complete a prefeasibility study as soon as possible ...read more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 1:08pm
PHIO....getting cheaper every minute....problem is
volume is decreasing also...currently at $2.05 No position
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 12:53pm
PHIO.... 50% retracement from the H.O.D
might be a starting point for the "Gamblers" Me no position
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Comment by
Iseneschal
on Oct 11, 2023 12:43pm
RE:Athx halted for 2 hours
wrong board
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 11:33am
PHIO....Is that all ya got
Your past history show huge candles Not today ????
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 11:14am
PHIO....All this thing does is Reverse Split and raise $'s
Hurry up and go down !!!!!
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 11:09am
PHIO.... compare how this nano float trades
compared to TPST Phio is a dog
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 10:53am
PHIO....I'll be a dip buyer on this
sub $2....somewhere ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Oct 11, 2023 10:41am
PHIO......I failed to mention this nano float this a.m
Sheesh.....I tend to think that this could relly take off...yes ...even from the $2 mark There a ton of people that are in at way higher prices I have no position The last financing was at over $4
...more
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2022 1:25pm
PHIO ..... N.L.O.D ..... thatta boy Mr. M
Can we take her a little lower Mr. Maggot ?
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2022 12:34pm
PHIO ..... Heading to the "woodshed" for another a$$ whoopin
THanks to Mr. Maggot ; )
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2022 12:08pm
PHIO ....."sideways action" til it either Pops or Drops ; )
Place ur bets! TRading range is $1.37 to $1.47....buy low sell high ; ) Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2022 10:45am
PHIO ....how low can u go ?
It will bottom sooner or later At support ? Cheers !
(57)
•••
Iseneschal
X
View Profile
View Bullboard History
Post by
Iseneschal
on Apr 12, 2022 10:05am
PHIO .... In PB mode ....low of $1.49
Consider yourself "spear-catching" now Me ...no position since yesterday..... Cheers !
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Centurion Identifies High Quality Gold Target-Casa Berardi West Project; Acquires Additional Claims
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study
Two New Contracts Awarded Covering Five Onshore Fields Producing 3,000 bbl/d of Oil
Fresh Insight into the Topaz HELIUM Project's Expected Size and Scale
Exploration company provides project portfolio update